BACKGROUND: In 2003, human monkeypox was first identified in the United States. The outbreak was associated with exposure to infected prairie dogs, but the potential for person-to-person transmission was a concern. This study examines health care worker (HCW) exposure to 3 patients with confirmed monkeypox. METHODS: Exposed HCWs, defined as HCWs who entered a 2-m radius surrounding case patients with confirmed monkeypox, were identified by infection-control practitioners. A self-administered questionnaire and analysis of paired serum specimens determined exposure status, immune response, and postexposure signs and symptoms of monkeypox. RESULTS: Of 81 exposed HCWs, 57 (70%) participated in the study. Among 57 participants, 40 (70%) had > or =1 unprotected exposure; none reported signs or symptoms consistent with monkeypox illness. One exposed HCW (2%), who had been vaccinated for smallpox within the past year, had serological evidence of recent orthopoxvirus infection; acute- and convalescent-phase serum specimens tested positive for anti-orthopoxvirus IgM. No exposed HCWs had signs and symptoms consistent with monkeypox. CONCLUSION: More than three-quarters of exposed HCWs reported at least 1 unprotected encounter with a patient who had monkeypox. One asymptomatic HCW showed laboratory evidence of recent orthopoxvirus infection, which was possibly attributable to either recent infection or smallpox vaccination. Transmission of monkeypox likely is a rare event in the health care setting.
BACKGROUND: In 2003, human monkeypox was first identified in the United States. The outbreak was associated with exposure to infected prairie dogs, but the potential for person-to-person transmission was a concern. This study examines health care worker (HCW) exposure to 3 patients with confirmed monkeypox. METHODS: Exposed HCWs, defined as HCWs who entered a 2-m radius surrounding case patients with confirmed monkeypox, were identified by infection-control practitioners. A self-administered questionnaire and analysis of paired serum specimens determined exposure status, immune response, and postexposure signs and symptoms of monkeypox. RESULTS: Of 81 exposed HCWs, 57 (70%) participated in the study. Among 57 participants, 40 (70%) had > or =1 unprotected exposure; none reported signs or symptoms consistent with monkeypox illness. One exposed HCW (2%), who had been vaccinated for smallpox within the past year, had serological evidence of recent orthopoxvirus infection; acute- and convalescent-phase serum specimens tested positive for anti-orthopoxvirus IgM. No exposed HCWs had signs and symptoms consistent with monkeypox. CONCLUSION: More than three-quarters of exposed HCWs reported at least 1 unprotected encounter with a patient who had monkeypox. One asymptomatic HCW showed laboratory evidence of recent orthopoxvirus infection, which was possibly attributable to either recent infection or smallpox vaccination. Transmission of monkeypox likely is a rare event in the health care setting.
Authors: Kate Varela; Jennifer A Brown; Beth Lipton; John Dunn; Danielle Stanek; Casey Barton Behravesh; Helena Chapman; Terry H Conger; Tiffany Vanover; Thomas Edling; Stacy Holzbauer; Angela M Lennox; Scott Lindquist; Suzan Loerzel; Shelley Mehlenbacher; Mark Mitchell; Michael Murphy; Christopher W Olsen; Cody M Yager Journal: Vector Borne Zoonotic Dis Date: 2022-06 Impact factor: 2.523
Authors: Faisal S Minhaj; Yasmin P Ogale; Florence Whitehill; Jordan Schultz; Mary Foote; Whitni Davidson; Christine M Hughes; Kimberly Wilkins; Laura Bachmann; Ryan Chatelain; Marisa A P Donnelly; Rafael Mendoza; Barbara L Downes; Mellisa Roskosky; Meghan Barnes; Glen R Gallagher; Nesli Basgoz; Victoria Ruiz; Nang Thu Thu Kyaw; Amanda Feldpausch; Amy Valderrama; Francisco Alvarado-Ramy; Chad H Dowell; Catherine C Chow; Yu Li; Laura Quilter; John Brooks; Demetre C Daskalakis; R Paul McClung; Brett W Petersen; Inger Damon; Christina Hutson; Jennifer McQuiston; Agam K Rao; Ermias Belay; Andrea M McCollum Journal: MMWR Morb Mortal Wkly Rep Date: 2022-06-10 Impact factor: 35.301
Authors: Erika Hammarlund; Anindya Dasgupta; Clemencia Pinilla; Patricia Norori; Klaus Früh; Mark K Slifka Journal: Proc Natl Acad Sci U S A Date: 2008-09-16 Impact factor: 11.205
Authors: Adam Macneil; Mary G Reynolds; Zach Braden; Darin S Carroll; Vanda Bostik; Kevin Karem; Scott K Smith; Whitni Davidson; Yu Li; Amba Moundeli; Jean-Vivien Mombouli; Aisha O Jumaan; D Scott Schmid; Russell L Regnery; Inger K Damon Journal: Clin Infect Dis Date: 2009-01-01 Impact factor: 9.079
Authors: Jennifer Bass; Danielle M Tack; Andrea M McCollum; Joelle Kabamba; Elisabeth Pakuta; Jean Malekani; Beatrice Nguete; Benjamin P Monroe; Jeffrey B Doty; Stomy Karhemere; Inger K Damon; Marcel Balilo; Emile Okitolonda; Robert L Shongo; Mary G Reynolds Journal: Int Health Date: 2013-11-17 Impact factor: 2.473
Authors: Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon Journal: Emerg Infect Dis Date: 2007-09 Impact factor: 6.883
Authors: Donita R Croft; Mark J Sotir; Carl J Williams; James J Kazmierczak; Mark V Wegner; Darren Rausch; Mary Beth Graham; Seth L Foldy; Mat Wolters; Inger K Damon; Kevin L Karem; Jeffrey P Davis Journal: Emerg Infect Dis Date: 2007-08 Impact factor: 6.883